Download FREE Report Sample
Download Free sampleMultiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which collect near the bone marrow and hamper normal functioning of the healthy plasma cells.
Multiple Myeloma Therapy Market contains market size and forecasts of Multiple Myeloma Therapy in Global, including the following market information:
Global Multiple Myeloma Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Multiple Myeloma Therapy market was valued at 11950 million in 2021 and is projected to reach US$ 28060 million by 2028, at a CAGR of 13.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Multiple Myeloma Therapy include Sanofi, Celgene, Johnson & Johnson, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc., Novartis AG and Millennium Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Multiple Myeloma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multiple Myeloma Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Multiple Myeloma Therapy Market Segment Percentages, by Type, 2021 (%)
Targeted Therapy
Chemotherapy
Radiotherapy
Bone Marrow Transplant
Others
Global Multiple Myeloma Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Multiple Myeloma Therapy Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Multiple Myeloma Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Multiple Myeloma Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multiple Myeloma Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Multiple Myeloma Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Celgene
Johnson & Johnson
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd
AbbVie Inc.
Amgen Inc.
Novartis AG
Millennium Pharmaceuticals
Innate Pharma SA
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
